Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 09/14/17
Due: 09/14/18
Phase: N/A
Priority: Normal
Start: 12/19/17
End: 12/31/23
Due: 12/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases | NCT02582749 | Ajjai Alva, MD | user2@example.com | None | 2016-04-30 | 2017-09-14 | 2018-09-14 | - | - | 2025-07-14 |
| Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer | NCT03308396 | Ajjai Alva, MD | user2@example.com | None | 2017-12-19 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |